US 12,186,080 B2
Fluid diversion mechanism for bodily-fluid sampling
Gregory J. Bullington, Seattle, WA (US); Richard G. Patton, Seattle, WA (US); Jay M. Miazga, Langley, WA (US); and Shan E. Gaw, Seattle, WA (US)
Assigned to Magnolia Medical Technologies, Inc., Seattle, WA (US)
Filed by Magnolia Medical Technologies, Inc., Seattle, WA (US)
Filed on May 28, 2024, as Appl. No. 18/676,186.
Application 18/676,186 is a continuation of application No. 17/863,605, filed on Jul. 13, 2022, abandoned.
Application 17/863,605 is a continuation of application No. 17/532,382, filed on Nov. 22, 2021, granted, now 11,395,612, issued on Jul. 26, 2022.
Application 17/532,382 is a continuation of application No. 17/525,682, filed on Nov. 12, 2021, granted, now 11,395,611, issued on Jul. 26, 2022.
Application 17/525,682 is a continuation of application No. 16/376,745, filed on Apr. 5, 2019, abandoned.
Application 16/376,745 is a continuation of application No. 14/662,676, filed on Mar. 19, 2015, granted, now 10,292,633, issued on May 21, 2019.
Application 14/662,676 is a continuation of application No. 14/494,208, filed on Sep. 23, 2014, granted, now 9,022,951, issued on May 5, 2015.
Application 14/494,208 is a continuation of application No. 14/493,796, filed on Sep. 23, 2014, granted, now 9,022,950, issued on May 5, 2015.
Application 14/493,796 is a continuation of application No. PCT/US2013/043289, filed on May 30, 2013.
Application PCT/US2013/043289 is a continuation in part of application No. 13/904,691, filed on May 29, 2013, granted, now 9,060,724, issued on Jun. 23, 2015.
Claims priority of provisional application 61/652,887, filed on May 30, 2012.
Prior Publication US 2024/0306964 A1, Sep. 19, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/15 (2006.01); A61B 5/153 (2006.01); A61B 5/155 (2006.01); A61B 10/00 (2006.01)
CPC A61B 5/150221 (2013.01) [A61B 5/15003 (2013.01); A61B 5/150236 (2013.01); A61B 5/150244 (2013.01); A61B 5/150251 (2013.01); A61B 5/150389 (2013.01); A61B 5/150503 (2013.01); A61B 5/150992 (2013.01); A61B 5/153 (2013.01); A61B 5/155 (2013.01); A61B 10/0048 (2013.01); A61B 10/0051 (2013.01); A61B 10/007 (2013.01); A61B 2010/0061 (2013.01); A61B 2010/0077 (2013.01); A61B 2010/008 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method of using a blood transfer device to reduce contamination in blood samples, the blood transfer device including a housing having an inlet port and an outlet port, the method comprising:
establishing fluid communication between the inlet port and a patient while the blood transfer device is in a first configuration, the blood transfer device in the first configuration being such that (i) a first flow path is in fluid communication with the inlet port and (ii) a portion of a second flow path is obstructed;
receiving a flow of blood from the inlet port and through the first flow path;
transitioning the blood transfer device from the first configuration to a second configuration when a first volume of blood is contained in an inner volume defined by the housing; and
receiving a subsequent flow of blood from the inlet port, through the second flow path, and to the outlet port while bypassing contaminants contained in the first volume of blood.